Ex Parte Auer et al - Page 6


                  Appeal No.  2004-2079                                                           Page 6                   
                  Application No.  09/754,958                                                                              
                  bond, is not fluorescent, thus it is unclear how moiety “B” allows cleavage of a                         
                  fluorescent conjugate, as set forth in claim 17.                                                         
                         Nevertheless, as it relates to a compound comprising the structure “A-B-                          
                  D-”, moiety “B” is a linker allowing cleavage for liberation of D - a bond.                              
                  Accordingly, based on this interpretation of claim 17, the claim comprises a solid                       
                  support attached to a linker that allows cleavage for liberation of a bond.  This                        
                  appears to be inconsistent with the statement in the specification (page 1, first                        
                  paragraph),                                                                                              
                         The present invention relates to the field of ultra high-throughput                               
                         screening on the solid support and in homogeneous solution by a                                   
                         novel generic labeling technology.  The new labeling technology is                                
                         based on new chemically stable fluorophores, which possess                                        
                         reactive chemical functionalities for attachment to a solid support                               
                         and subsequent start of combinatorial synthesis of compound                                       
                         libraries.                                                                                        
                                                                                                                          
                  There is no requirement in claim 17 that compounds comprising the structure  “A-                         
                  B-D-” contain a fluorophore.  While other interpretations of the claim may be                            
                  possible, they would only serve to emphasize that the claim is indefinite.  For                          
                  example, as discussed infra, the structures recited in claim 19 (“A-B-C-D'-E,” “A-                       
                  B-E-C,” “A-B-E-D'-C,” and “A-B-D-E-C”) open the scope of claim 17 to read on                             
                  internal modifications to the structures of formula II and formula III.  As set forth,                   
                  infra, appellants have provided no precedent to support such a modification of                           
                  the structures set forth in claim 17.                                                                    
                  “Open-ended” recitations:                                                                                
                         In this regard, we note that the recitation of formula II and formula III as                      
                  they appear in claim 17 are inconsistent with the description of formula II and                          
                  formula III as they appear on pages 7 and 8 of appellants’ specification.                                





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007